Stay updated with breaking news from Cardinal symptoms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LYRA THERAPEUTICS announces additional data presentations FROM PHASE 2 LANTERN STUDY at the americal rhinologic society annual meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Air Pollution can Cause Loss of Smell by Hannah Joy on May 31, 2021 at 3:56 PM Prolonged exposure to air pollution can cause anosmia (loss of smell) Loss of smell can be one of the primary and major risk factors for Covid-19 infection Exposure to particulate matter (PM) 2.5 increases the risk of losing one s smell by nearly twice People who are exposed to particulate matter (PM) 2.5 for a long time are two times more at risk of losing the sense of smell, reveals a new study. The loss of smell, a condition known as anosmia, can severely impact a person s quality of life, making it extremely difficult to taste foods, detect airborne hazards in the environment, and carry out other functions dependent on the senses. ....
New data presented includes: - First product candidate found to be effective in non-polyp patients in addition to polyp patients in a clinical trial, based on 100% of patients in both groups achieving SNOT-22 MCID at week 24 with LYR-210 (7500µg group) - - LYR-210 (7500µg) decreased ethmoid opacification at week 24, a measure of disease modification - - LYR-210 (7500µg) reduced the need for rescue medication - - Separately, Lyra also reported an analysis showing that LYR-210 (7500µg) achieved statistically significant improvement across 3 cardinal symptoms at week 24 in the LANTERN study - Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today presented data from its Phase 2 LANTERN study of LYR-210, the company’s lead long-acting product candidate fo ....
Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
KARDINÁLIS TÜNETEK es.hu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from es.hu Daily Mail and Mail on Sunday newspapers.